Study for the efficacy and safety of branch adrenal vein sampling via subclavian vein and femoral vein

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023620

Enrollment

Unknown

Registered

2019-06-04

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adrenal adenoma

Interventions

experimental group:adrenal vein sampling via subclavian vein apporch

control group:adrenal vein sampling via femoral vein approach

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Continuous blood pressure>160/100mmHgrefractory hypertension; 2. Hypertension with hypokalemia caused by spontaneous or diuretics; 3. Hypertension combined adrenal accidental tumors; 4. Early-onset hypertension family history or Early onset accident hypertension patients with family history; 5. hypertension in patients with primary aldosteronism first-degree relatives; 6. Patients with written informed consent; 7. Aged 18 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Primary hypertension; 2. doubt adrenal cortical carcinoma by computed imaging; 3. patients aged <40 years with marked PA and a clear unilateral adrenal adenoma and a normal contralateral adrenal gland on; 4. Allergy to contrast; 5. Liver and kidney dysfunction and blood coagulation dysfunction; 6. The patient and family members refuse surgery.

Design outcomes

Primary

Measure	Time frame
aldosterone/cortisol ratio;	—

Secondary

Measure	Time frame
Surgical complications;Total operation time;	—

Countries

China

Contacts

Public ContactZijun Chen

Yongchuan Hospital Affiliated to Chongqing Medical University

chenzijun@cqmu.edu.cn+86 13648313737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026